Page last updated: 2024-10-30

mesalamine and Rectovaginal Fistula

mesalamine has been researched along with Rectovaginal Fistula in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Rectovaginal Fistula: An abnormal anatomical passage between the RECTUM and the VAGINA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodríguez-Grau, Mdel C1
Chaparro, M1
Díaz, R1
Gisbert, JP1
Soto-Fernández, S1
González-Carro, P1
De Pedro-Esteban, A1
Legaz-Huidobro, ML1
Pérez-Roldán, F1
Roncero García-Escribano, O1
Valbuena-González, M1
Ruiz-Carrillo, F1

Other Studies

2 other studies available for mesalamine and Rectovaginal Fistula

ArticleYear
[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].
    Gastroenterologia y hepatologia, 2014, Volume: 37, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Resistance;

2014
[Infliximab-induced hepatitis in a patient with Crohn's disease].
    Gastroenterologia y hepatologia, 2006, Volume: 29, Issue:5

    Topics: Acute Disease; Adult; Antibodies, Monoclonal; Azathioprine; Chemical and Drug Induced Liver Injury;

2006